246 related articles for article (PubMed ID: 25551281)
1. Integrative network analysis of TCGA data for ovarian cancer.
Zhang Q; Burdette JE; Wang JP
BMC Syst Biol; 2014 Dec; 8():1338. PubMed ID: 25551281
[TBL] [Abstract][Full Text] [Related]
2. Integrative prediction of gene function and platinum-free survival from genomic and epigenetic features in ovarian cancer.
Wrzeszczynski KO; Varadan V; Kamalakaran S; Levine DA; Dimitrova N; Lucito R
Methods Mol Biol; 2013; 1049():35-51. PubMed ID: 23913207
[TBL] [Abstract][Full Text] [Related]
3. ICan: an integrated co-alteration network to identify ovarian cancer-related genes.
Zhou Y; Liu Y; Li K; Zhang R; Qiu F; Zhao N; Xu Y
PLoS One; 2015; 10(3):e0116095. PubMed ID: 25803614
[TBL] [Abstract][Full Text] [Related]
4. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
[TBL] [Abstract][Full Text] [Related]
5. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
6. Integrative network analysis for survival-associated gene-gene interactions across multiple genomic profiles in ovarian cancer.
Jeong HH; Leem S; Wee K; Sohn KA
J Ovarian Res; 2015 Jul; 8():42. PubMed ID: 26138921
[TBL] [Abstract][Full Text] [Related]
7. Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
Verbeke LP; Van den Eynden J; Fierro AC; Demeester P; Fostier J; Marchal K
PLoS One; 2015; 10(7):e0133503. PubMed ID: 26217958
[TBL] [Abstract][Full Text] [Related]
8. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
Zhang J; Zhang S; Wang Y; Zhang XS
BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
[TBL] [Abstract][Full Text] [Related]
9. Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers.
Gloss BS; Patterson KI; Barton CA; Gonzalez M; Scurry JP; Hacker NF; Sutherland RL; O'Brien PM; Clark SJ
Cancer Lett; 2012 May; 318(1):76-85. PubMed ID: 22155104
[TBL] [Abstract][Full Text] [Related]
10. The functional consequences and prognostic value of dosage sensitivity in ovarian cancer.
Yan Z; Liu Y; Wei Y; Zhao N; Zhang Q; Wu C; Chang Z; Xu Y
Mol Biosyst; 2017 Jan; 13(2):380-391. PubMed ID: 28067383
[TBL] [Abstract][Full Text] [Related]
11. Reducing confounding and suppression effects in TCGA data: an integrated analysis of chemotherapy response in ovarian cancer.
Hsu FH; Serpedin E; Hsiao TH; Bishop AJ; Dougherty ER; Chen Y
BMC Genomics; 2012; 13 Suppl 6(Suppl 6):S13. PubMed ID: 23134756
[TBL] [Abstract][Full Text] [Related]
12. Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
Kundu S; Cheng Y; Shin M; Manyam G; Mallick BK; Baladandayuthapani V
PLoS One; 2018; 13(7):e0195070. PubMed ID: 30059495
[TBL] [Abstract][Full Text] [Related]
13. Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis.
Song X; Ji J; Gleason KJ; Yang F; Martignetti JA; Chen LS; Wang P
Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S52-S65. PubMed ID: 31227599
[TBL] [Abstract][Full Text] [Related]
14. [An integrative bioinformatics study of DNA copy number variation and differentially expressed genes in ovarian cancer].
Deng Z; Wang W; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(6):813-7. PubMed ID: 24968836
[TBL] [Abstract][Full Text] [Related]
15. Incorporating genetic networks into case-control association studies with high-dimensional DNA methylation data.
Kim K; Sun H
BMC Bioinformatics; 2019 Oct; 20(1):510. PubMed ID: 31640538
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment.
Barton CA; Hacker NF; Clark SJ; O'Brien PM
Gynecol Oncol; 2008 Apr; 109(1):129-39. PubMed ID: 18234305
[TBL] [Abstract][Full Text] [Related]
17. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood DNA methylation detected in the BRCA1 or BRCA2 promoter for sporadic ovarian cancer patients and controls.
Bosviel R; Michard E; Lavediaux G; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
Clin Chim Acta; 2011 Jul; 412(15-16):1472-5. PubMed ID: 21557934
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
[TBL] [Abstract][Full Text] [Related]
20. InterSIM: Simulation tool for multiple integrative 'omic datasets'.
Chalise P; Raghavan R; Fridley BL
Comput Methods Programs Biomed; 2016 May; 128():69-74. PubMed ID: 27040832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
